Jinling Pharmaceutical Company Limited (000919.SZ)
CNY 6.21
(0.81%)
CNY 6.21
(0.81%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 249.63 Million CNY | 16.09% |
| 2022 | 254.72 Million CNY | -29.95% |
| 2021 | 325.5 Million CNY | 4.13% |
| 2020 | 236.41 Million CNY | -35.13% |
| 2019 | 312.76 Million CNY | -4.62% |
| 2018 | 483.61 Million CNY | 34.28% |
| 2017 | 334.55 Million CNY | -10.7% |
| 2016 | 390.92 Million CNY | -8.85% |
| 2015 | 429.75 Million CNY | 9.89% |
| 2014 | 388.83 Million CNY | 20.7% |
| 2013 | 321.71 Million CNY | 23.76% |
| 2012 | 296.98 Million CNY | -22.31% |
| 2011 | 323.2 Million CNY | 0.39% |
| 2010 | 328.23 Million CNY | -6.38% |
| 2009 | 363.91 Million CNY | 89.18% |
| 2008 | 170.12 Million CNY | -54.96% |
| 2007 | 483.21 Million CNY | 28.86% |
| 2006 | 342.86 Million CNY | 23.99% |
| 2005 | 272.02 Million CNY | 34.52% |
| 2004 | 202.22 Million CNY | -8.58% |
| 2003 | 221.2 Million CNY | 8.78% |
| 2002 | 203.34 Million CNY | 20.37% |
| 2001 | 169.64 Million CNY | 35.34% |
| 2000 | 121.82 Million CNY | -9.53% |
| 1999 | 137.96 Million CNY | 19.48% |
| 1998 | 114.95 Million CNY | 15.24% |
| 1997 | 100.2 Million CNY | 170.28% |
| 1996 | 37.07 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 20.26 Million CNY | -59.9% |
| 2024 Q2 | 52.77 Million CNY | -47.08% |
| 2024 Q1 | 63.67 Million CNY | 276.57% |
| 2023 Q4 | -8.04 Million CNY | -129.92% |
| 2023 Q2 | 44.5 Million CNY | -25.31% |
| 2023 Q3 | 26.9 Million CNY | -39.54% |
| 2023 Q1 | 59.58 Million CNY | 289.25% |
| 2023 FY | - CNY | 16.09% |
| 2022 Q3 | 28.26 Million CNY | -17.88% |
| 2022 Q1 | 63.45 Million CNY | 743.92% |
| 2022 Q2 | 34.41 Million CNY | -45.77% |
| 2022 FY | - CNY | -29.95% |
| 2022 Q4 | -31.48 Million CNY | -211.42% |
| 2021 Q1 | 73.37 Million CNY | 1739.8% |
| 2021 FY | - CNY | 4.13% |
| 2021 Q4 | 7.51 Million CNY | -88.36% |
| 2021 Q2 | 44.17 Million CNY | -39.8% |
| 2021 Q3 | 64.61 Million CNY | 46.29% |
| 2020 Q2 | 27.13 Million CNY | 65.96% |
| 2020 Q4 | 3.98 Million CNY | -94.8% |
| 2020 Q3 | 76.67 Million CNY | 182.61% |
| 2020 FY | - CNY | -35.13% |
| 2020 Q1 | 16.34 Million CNY | -85.37% |
| 2019 Q1 | -165.34 Million CNY | -205.53% |
| 2019 FY | - CNY | -4.62% |
| 2019 Q2 | 315.6 Million CNY | 290.88% |
| 2019 Q3 | 78.35 Million CNY | -75.17% |
| 2019 Q4 | 111.78 Million CNY | 42.65% |
| 2018 FY | - CNY | 34.28% |
| 2018 Q3 | 50.85 Million CNY | -45.19% |
| 2018 Q2 | 92.77 Million CNY | 50.4% |
| 2018 Q1 | 61.68 Million CNY | -8.66% |
| 2018 Q4 | 156.67 Million CNY | 208.1% |
| 2017 Q1 | 54.9 Million CNY | -37.47% |
| 2017 Q2 | 105.34 Million CNY | 91.88% |
| 2017 Q3 | 38.2 Million CNY | -63.74% |
| 2017 Q4 | 67.53 Million CNY | 76.79% |
| 2017 FY | - CNY | -10.7% |
| 2016 Q1 | 67.1 Million CNY | -39.58% |
| 2016 Q4 | 87.8 Million CNY | 47.56% |
| 2016 FY | - CNY | -8.85% |
| 2016 Q3 | 59.5 Million CNY | -40.58% |
| 2016 Q2 | 100.13 Million CNY | 49.21% |
| 2015 Q2 | 139.45 Million CNY | 143.3% |
| 2015 Q4 | 111.06 Million CNY | 48.22% |
| 2015 Q3 | 74.93 Million CNY | -46.27% |
| 2015 Q1 | 57.31 Million CNY | -47.16% |
| 2015 FY | - CNY | 9.89% |
| 2014 FY | - CNY | 20.7% |
| 2014 Q3 | 56.88 Million CNY | -45.38% |
| 2014 Q1 | 63.73 Million CNY | -25.01% |
| 2014 Q2 | 104.15 Million CNY | 63.43% |
| 2014 Q4 | 108.47 Million CNY | 90.69% |
| 2013 Q1 | 45.37 Million CNY | -20.04% |
| 2013 Q3 | 40.66 Million CNY | -56.37% |
| 2013 Q4 | 84.98 Million CNY | 108.99% |
| 2013 Q2 | 93.2 Million CNY | 105.4% |
| 2013 FY | - CNY | 23.76% |
| 2012 Q2 | 80.89 Million CNY | 125.6% |
| 2012 Q3 | 30.6 Million CNY | -62.16% |
| 2012 FY | - CNY | -22.31% |
| 2012 Q4 | 56.74 Million CNY | 85.39% |
| 2012 Q1 | 35.85 Million CNY | -55.03% |
| 2011 Q2 | 117.07 Million CNY | 179.41% |
| 2011 Q1 | 41.9 Million CNY | -59.58% |
| 2011 FY | - CNY | 0.39% |
| 2011 Q4 | 79.72 Million CNY | 44.79% |
| 2011 Q3 | 55.06 Million CNY | -52.97% |
| 2010 Q3 | 7.75 Million CNY | -91.89% |
| 2010 Q1 | 50.93 Million CNY | -55.77% |
| 2010 Q4 | 103.66 Million CNY | 1236.89% |
| 2010 FY | - CNY | -6.38% |
| 2010 Q2 | 95.57 Million CNY | 87.64% |
| 2009 Q4 | 115.16 Million CNY | 59.5% |
| 2009 Q3 | 72.2 Million CNY | -22.56% |
| 2009 Q2 | 93.24 Million CNY | 38.57% |
| 2009 Q1 | 67.29 Million CNY | 165.59% |
| 2009 FY | - CNY | 89.18% |
| 2008 Q1 | 97.18 Million CNY | -73.47% |
| 2008 FY | - CNY | -54.96% |
| 2008 Q4 | -102.59 Million CNY | -469.64% |
| 2008 Q3 | 27.75 Million CNY | 10.86% |
| 2008 Q2 | 25.03 Million CNY | -74.24% |
| 2007 Q3 | -7.04 Million CNY | -103.19% |
| 2007 Q1 | -4.26 Million CNY | -102.49% |
| 2007 FY | - CNY | 28.86% |
| 2007 Q4 | 366.32 Million CNY | 5296.91% |
| 2007 Q2 | 221 Million CNY | 5275.9% |
| 2006 Q2 | 117.04 Million CNY | 160.49% |
| 2006 Q4 | 171.5 Million CNY | 259.66% |
| 2006 Q3 | 47.68 Million CNY | -59.26% |
| 2006 Q1 | 44.93 Million CNY | -45.26% |
| 2006 FY | - CNY | 23.99% |
| 2005 Q3 | 47.95 Million CNY | -35.31% |
| 2005 FY | - CNY | 34.52% |
| 2005 Q2 | 74.13 Million CNY | 25.1% |
| 2005 Q1 | 59.25 Million CNY | 39.86% |
| 2005 Q4 | 82.08 Million CNY | 71.18% |
| 2004 Q3 | 43.42 Million CNY | -12.44% |
| 2004 Q2 | 49.59 Million CNY | 13.55% |
| 2004 FY | - CNY | -8.58% |
| 2004 Q1 | 43.67 Million CNY | -56.45% |
| 2004 Q4 | 42.36 Million CNY | -2.44% |
| 2003 Q3 | 21.42 Million CNY | -70.8% |
| 2003 FY | - CNY | 8.78% |
| 2003 Q1 | 44.39 Million CNY | -42.65% |
| 2003 Q4 | 100.29 Million CNY | 368.17% |
| 2003 Q2 | 73.37 Million CNY | 65.28% |
| 2002 FY | - CNY | 20.37% |
| 2002 Q4 | 77.4 Million CNY | 1891.78% |
| 2002 Q3 | -4.32 Million CNY | -105.24% |
| 2002 Q2 | 82.4 Million CNY | 256.12% |
| 2002 Q1 | 151.81 Million CNY | 0.0% |
| 2001 FY | - CNY | 35.34% |
| 2000 FY | - CNY | -9.53% |
| 1999 FY | - CNY | 19.48% |
| 1998 FY | - CNY | 15.24% |
| 1997 FY | - CNY | 170.28% |
| 1996 FY | - CNY | 0.0% |